Charles Tuttle

Relentlessly mission-oriented. No ego. And a superb sense of humor. Who could want for more? Happy Birthday Mr. Secretary.

Southampton, England (May 28)—A crowd gathered at Central Police Station to demand police footage be released in the arrest of Henry Nowak, the white student who was handcuffed after being stabbed by a migrant. He bled out & died. Video by @actualcoverage:

Oil is heading for a big weekly drop on Hormuz deal hopes. That can change the tone fast. Energy names may cool. Airlines and transports may catch attention. But don’t trade the headline alone. Trade the reaction. reut.rs/4fLf02b

WOWOWOWOWOW $DELL NOW UP 40% AFTERHOURS....CONGRATS TO ALL LONGS, ITS WAVE AFTER WAVE AFTER WAVE, SAME PATTERN AS ALWAYS, LEARN FROM THIS 2014 VIDEO ABOUT EARNINGS WINNERS youtube.com/watch?v=JITy6E… CONGRATS TO ALL LONGS!!

Governor DeSantis says it's necessary to remove illegal laiens to prevent further crime before they reoffend: "Waiting for someone to be convicted is not smart. I want to identify and remove them BEFORE our citizens get victimized."

#Beauty #BrokenEggs #GreatResult when a few eggs are broke, scrambled, & combined with vegetables/cream cheese; result is fabulous.

Headline-driven markets move fast. But speed does not equal quality. A headline can get a stock on your radar. A clean chart, real volume, and defined risk decide whether it belongs in your plan.

Courage doesn’t simply mean you have deep convictions. It means you are willing to make a sacrifice to advance those convictions, even at considerable personal loss.

The Columbus Circle fountain at Union Station has been dry since before the first iPhone launched. 🤯 For the first time since 2007, the fountain is flowing again. Thanks to @POTUS, we are making our Nation’s Capital safe, beautiful and worthy of the greatest nation on Earth. 🇺🇸

LOL @StocksToTrade BREAKING NEWS is a tool here that I use daily, try it tim.ly/breaking3 and save me time from having to repeat myself...my God, we have the absolute laziest, most twisted people in this industry. Somehow knocking a play that gets alerted and goes up nearly 30x, study up and give me 5000 burpees to atone for your personality disorder

Earlier today it was another beautifulllllll day here on the #amalficoast with my giant lemons as we’re squeezing the short sellers like the bitter lemons they are with $ASTC now spiking alllllll the way up to $69/share from when @stockstotrade breaking news alerted the key news catalyst at $2.50/share so it’s up 27x in just 2 days now!!! My trainer was trying to get me to workout, but the #stockmarket is INSANE right now so I’m trying my best to multitask! Congratulations to sooooooo many students, what a day/week/month, whewwwwwww! And no PDT rule next week is gonna make everything even crazier — DO YOU PROMISE TO CAPITALIZE??? #stocktrading #shortsqueeze

BREAKING: Largest Human Cancer Study of Ivermectin + Mebendazole Is Now PEER-REVIEWED and PUBLISHED in a MAJOR Cancer Journal 84.4% of cancer patients taking ivermectin + mebendazole for 6 months declared either CANCER DISAPPEARANCE, TUMOR REGRESSION, or CANCER STABILIZATION. Our study, “Real-world Clinical Outcomes of Ivermectin and Mebendazole in Cancer Patients: Results from a Prospective Observational Cohort,” is now peer-reviewed and published in Anticancer Research—a major international oncology journal of the International Institute of Anticancer Research (IIAR), established in 1995. The results represent one of the most compelling clinical signals ever documented for repurposed anti-parasitic therapies in oncology. A diverse population of cancer patients (n=197) was prescribed compounded ivermectin–mebendazole through a U.S. telemedicine platform, with each capsule containing 25 mg ivermectin and 250 mg mebendazole. Participants were followed for approximately six months using standardized digital surveys assessing cancer outcomes, medication adherence, and tolerability. At approximately six months post-treatment initiation, we observed an 84.4% Clinical Benefit Ratio (CBR)—meaning more than four out of five patients reported either: No evidence of disease (32.8%) Tumor regression (15.6%) or Cancer stabilization (36.1%) Importantly, adherence was remarkably high, with 86.9% completing the initial prescription and 66.4% remaining on therapy at six months. Side effects were predominantly mild and manageable, reported in 25.4% of patients (primarily gastrointestinal), with 93.6% of those experiencing side effects continuing treatment after minor dosing adjustments. This groundbreaking peer-reviewed publication was made possible through a unique collaboration between The Wellness Company, the McCullough Foundation, and the Chairman of the President’s Cancer Panel—uniting real-world clinical data, frontline medical experience, and epidemiologic expertise to evaluate inexpensive, repurposed therapies with major translational potential. With these extraordinarily promising results, double-blind, placebo-controlled clinical trials are now required. In the meantime, many cancer patients are exercising their right to try. @twc_health @McCulloughFund @IIAR_Journals @P_McCulloughMD @DrHarveyRisch @DrKellyVictory @jathorpmfm @drdrew @PeterGillooly @FosterCoulson

Took 2500 $QTEX at 2.50, sold at 3.15 for +$1,625. Singles add up @timothysykes

#ResistSuicide Suicidal Empathy | 5-Minute Videos | PragerU youtu.be/twFDX-QeOow?si… via @YouTube

🔥🚨DEVELOPING: This mother uploaded footage of her 15-year old son sounding nearly identical to the legendary Frank Sinatra singing “That’s Life” has left viewers across the internet speechless, his name is George Robinson.

#Laugh #Cry #AcceptReality youtube.com/shorts/5vAenUA…

#Believe #IfSaid youtube.com/shorts/5vAenUA…

Whewwww what a day/week/month as I’m here on the #amalficoast enjoying what could be the biggest lemon in the world and I can’t help but think about how it exemplifies just crazy huuuuuuge the short squeeze’s this month have been and short sellers everywhere are getting squeezed like the bitter lemons they are in the craziest way possible — and we’re still 6 days away from no PDT Rule which should take this party to the next level all summer long! You gotta love GIANT runners like $ASTC $QTEX $MNTS $AKTX $QUCY that are surging 300%, 500%, even 1,000%+ in the past few days alone — and it’s not just small companies, in the last 2 hours alone, $200+ billion company $DELL is now surging 40% afterhours after reporting earnings! Congrats to soooooo many of my students on really crushing it and learning the process, I’m sorry if I can’t keep up with all the messages and comments as it’s truly overwhelming right now and when the PDT Rule disappears next week it’s gonna get even crazier. If you want to learn, appy at tim.ly/sykeschallenge and get in my chatroom and weekly webinars as that’s the only place I teach! I have no time for private Q&A and if you think you’re DMing with me or Whatsapping or Telegramming with me, you’re not, those are ALL impostors/scammers so block/report them! #whenlifegivesyoulemons #biggestlemonever #shortsqueeze

Anytime you have a low priced sympathy play in the hottest sector trading the kind of volume $QTEX did on Friday it’s gotta be top of your list for a gapper into Monday morning. If you are curious for the before and after on this, check out my appearance on @@SchwabNetwork Friday at 11AM where I laid the idea out on $QTEX #bohenbreakdown